Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPSAB1 | Q15661 | 3/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.46 |
| ▸ | ANPEP | P15144 | 1/20 | 0.46 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 4/20 | 0.44 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ABAT | P80404 | 1/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9180552 | 0.87 | LMNA (0.52) | HRH3LMNAHRH4CYP1A2CYP2D6 | |
| SCHEMBL8500622 | 0.83 | PNMT (0.45) | LOXL2CYP1A2CYP2D6CYP2C9TSHR | |
| SCHEMBL18235915 | 0.82 | HRH3 (0.52) | TPSAB1HRH3ANPEPERAP2LOXL2 | |
| SCHEMBL12074568 | 0.81 | GFER (0.46) | HRH3ANPEPERAP2LOXL2LMNA | |
| SCHEMBL10052932 | 0.80 | LMNA (0.64) | HRH3LMNAHRH4CYP1A2CYP2D6 | |
| SCHEMBL18235879 | 0.79 | CHRM2 (0.55) | TPSAB1HRH3ANPEPERAP2LOXL2 | |
| SCHEMBL17715564 | 0.79 | HRH4 (0.63) | HRH3LMNAHRH4CYP1A2CYP2D6 | |
| SCHEMBL631818 | 0.78 | CHRM2 (0.59) | LMNACYP2D6CYP2C9CYP2C19SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL17710395 | 0.78 | LMNA (0.61) | HRH3LMNAHRH4CYP1A2CYP2D6 | |
| SCHEMBL21799537 | 0.77 | ANPEP (0.51) | TPSAB1HRH3ANPEPERAP2LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116134012-B | Method for producing aminomethyl aromatic | 三菱瓦斯化学株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-116134012-A | Method for producing aminomethyl aromatic | 三菱瓦斯化学株式会社 | 2023-05-16 | — | — | CN | disclosed |
| WO-2022019105-A1 | METHOD FOR PRODUCING AROMATIC AMINOMETHYL | 三菱瓦斯化学株式会社 | 2022-01-27 | — | — | WO | disclosed |
| US-11124593-B2 | Modified block copolymer, method for producing modified block copolymer, and resin composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-09-21 | — | — | US | disclosed |
| US-20200199282-A1 | Modified Block Copolymer, Method for Producing Modified Block Copolymer, and Resin Composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2020-06-25 | — | — | US | disclosed |
| EP-3623398-A1 | MODIFIED BLOCK COPOLYMER, METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER, AND RESIN COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2020-03-18 | — | — | EP | disclosed |
| US-9701628-B2 | 12-epi pleuromutilins | NABRIVA THERAPEUTICS AG (AT) | 2017-07-11 | — | — | US | disclosed |
| US-20160332963-A1 | 12-EPI PLEUROMUTILINS | Nabriva Therapeutics GmbH (AT) | 2016-11-17 | — | — | US | disclosed |
| WO-2015110481-A1 | 12-EPI-PLEUROMUTILINS | NABRIVA THERAPEUTICS AG (AT) | 2015-07-30 | — | — | WO | disclosed |
| US-20070185311-A1 | Peptide-Based Multimeric Targeted Contrast Agents | EPIX PHARMACEUTICALS, INC. (US) | 2007-08-09 | — | — | US | disclosed |
| US-7238341-B2 | Peptide-based multimeric targeted contrast agents | EPIX PHARMACEUTICALS, INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-20050074411-A1 | Peptide-based multimeric targeted contrast agents | EPIX MEDICAL, INC. A DELAWARE CORPORATION | 2005-04-07 | — | — | US | disclosed |
| EP-0558048-B1 | Thermoplastic resin composition | IDEMITSU PETROCHEMICAL CO (JP) | 1999-07-07 | — | — | EP | disclosed |
| US-5552480-A | BLEND, IMIDIZED ADDITION POLYMER, ENGINEERING PLASTIC, IMPACT STRENGTH | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1996-09-03 | — | — | US | disclosed |
| EP-0558048-A1 | Thermoplastic resin composition | IDEMITSU PETROCHEMICAL COMPANY LIMITED (JP) | 1993-09-01 | — | — | EP | disclosed |
| US-4142034-A | Epoxy resin compositions containing an amine-cyanic acid ester combination curing agent | CINCINNATI MILACRON INC. (US) | 1979-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185311-A1 | Peptide-Based Multimeric Targeted Contrast Agents | NGLY1, IAPP, NPPA | TPSAB1 2894/4885HRH3 2873/4885ANPEP 26/4885 |
| US-20050074411-A1 | Peptide-based multimeric targeted contrast agents | NGLY1, IAPP, NPPA | TPSAB1 2894/4885HRH3 2873/4885ANPEP 26/4885 |
| US-20160332963-A1 | 12-EPI PLEUROMUTILINS | MLN, TCF12, PLEC | TPSAB1 2578/4885HRH3 3275/4885ANPEP 663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.